Baidu
map

神经科

订阅

MedSci主页 / 所有栏目 / 神经科

司来吉兰可以单独用于年轻患者吗？剂量用多少合适？

2021-07-14 MedSci原创 MedSci原创

帕金森病司来吉兰
关注

司来吉兰可以单独用于年轻患者吗？剂量用多少合适？

《梅斯直播课：帕金森病的药物治疗和运动并发症》

回答问题4：司来吉兰可以单独用于年轻患者吗？剂量用多少合适？

 

欢迎点赞、评论、分享

 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1525707, encodeId=80a31525e078a, content=<a href='/topic/show?id=e96e489842a' target=_blank style='color:#2F92EE;'>#年轻患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48984, encryptionId=e96e489842a, topicName=年轻患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aab511654279, createdName=minzju5056, createdTime=Fri Jul 16 05:50:11 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999590, encodeId=7a0e9995907a, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Wed Jul 14 23:15:42 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999456, encodeId=4fd9999456df, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210620/18f5071e347e49ebb6f553689adbd5e5/1049fe8591ed4715aea12de25ec65b76.jpg, createdBy=57252430980, createdName=我爱医学是真的, createdTime=Wed Jul 14 16:47:36 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999417, encodeId=7e0e99941e58, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Wed Jul 14 15:21:34 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-16 minzju5056

    #年轻患者#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1525707, encodeId=80a31525e078a, content=<a href='/topic/show?id=e96e489842a' target=_blank style='color:#2F92EE;'>#年轻患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48984, encryptionId=e96e489842a, topicName=年轻患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aab511654279, createdName=minzju5056, createdTime=Fri Jul 16 05:50:11 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999590, encodeId=7a0e9995907a, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Wed Jul 14 23:15:42 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999456, encodeId=4fd9999456df, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210620/18f5071e347e49ebb6f553689adbd5e5/1049fe8591ed4715aea12de25ec65b76.jpg, createdBy=57252430980, createdName=我爱医学是真的, createdTime=Wed Jul 14 16:47:36 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999417, encodeId=7e0e99941e58, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Wed Jul 14 15:21:34 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 14775a26m11暂无昵称

    #帕金森病#学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1525707, encodeId=80a31525e078a, content=<a href='/topic/show?id=e96e489842a' target=_blank style='color:#2F92EE;'>#年轻患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48984, encryptionId=e96e489842a, topicName=年轻患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aab511654279, createdName=minzju5056, createdTime=Fri Jul 16 05:50:11 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999590, encodeId=7a0e9995907a, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Wed Jul 14 23:15:42 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999456, encodeId=4fd9999456df, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210620/18f5071e347e49ebb6f553689adbd5e5/1049fe8591ed4715aea12de25ec65b76.jpg, createdBy=57252430980, createdName=我爱医学是真的, createdTime=Wed Jul 14 16:47:36 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999417, encodeId=7e0e99941e58, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Wed Jul 14 15:21:34 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 我爱医学是真的

    厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1525707, encodeId=80a31525e078a, content=<a href='/topic/show?id=e96e489842a' target=_blank style='color:#2F92EE;'>#年轻患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48984, encryptionId=e96e489842a, topicName=年轻患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aab511654279, createdName=minzju5056, createdTime=Fri Jul 16 05:50:11 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999590, encodeId=7a0e9995907a, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Wed Jul 14 23:15:42 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999456, encodeId=4fd9999456df, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210620/18f5071e347e49ebb6f553689adbd5e5/1049fe8591ed4715aea12de25ec65b76.jpg, createdBy=57252430980, createdName=我爱医学是真的, createdTime=Wed Jul 14 16:47:36 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999417, encodeId=7e0e99941e58, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Wed Jul 14 15:21:34 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 智慧药

    学习了

    0

相关资讯

帕金森病的用药原则

帕金森病的用药原则

Molecular Psychiatry：研究表明：线粒体功能障碍是帕金森病的主要病因

帕金森病（Parkinson’s Disease，PD）

帕金森病人出现冻结现象怎么处理？

遇到冻结现象怎么处理？-张老师-第三个问题.

Brain Structure and Function：早期帕金森患者灰质网络存在异常

GM网络的拓扑组织在早期PD中被破坏，这表明信息处理的更大分离。这对早期影像诊断有潜在的应用价值。该研究的发现可能为理解PD的病理生理学提供新的见解。

Ann Neurol:肠道微生物特点，可有效预测帕金森

肠道微生物特点可有效预测帕金森

普拉克索如何加量？

普拉克索如何加量？

Baidu
map
Baidu
map
Baidu
map